Turner Investments’s Repligen RGEN Stock Holding History

Turner Investments’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,500	Closed	-$477K	–	196
2017 Q2	$477K	Sell	11,500 -500	-4%	-$19K	0.31%	97
2017 Q1	$422K	Buy	+12,000	New	+$380K	0.27%	118
2016 Q3	–	Sell	-59,000	Closed	-$1.61M	–	221
2016 Q2	$1.61M	Buy	59,000 +5,000	+9%	+$128K	0.51%	62
2016 Q1	$1.45M	Buy	54,000 +7,800	+17%	+$191K	0.39%	87
2015 Q4	$1.31M	Sell	46,200 -31,800	-41%	-$917K	0.27%	110
2015 Q3	$2.17M	Buy	78,000 +5,930	+8%	+$214K	0.44%	76
2015 Q2	$2.97M	Sell	72,070 -26,370	-27%	-$966K	0.54%	59
2015 Q1	$2.99M	Buy	98,440 +55,650	+130%	+$1.44M	0.54%	62
2014 Q4	$847K	Buy	+42,790	New	+$957K	0.1%	294

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Turner Investments's RGEN Position: Q3 2017 in Review

Turner Investments sold out of Repligen (RGEN) in Q3 2017, closing a stake of 11,500 shares — an estimated $477K sold.

Turner Investments first reported a position in RGEN in Q4 2014 and held it in 9 quarters. The position peaked at $2.99M in Q1 2015. 190 funds tracked by Wall St. Rank hold RGEN as of Q3 2017.

Turner Investments reported no remaining Repligen position as of Q3 2017 after selling out during the quarter.
Turner Investments sold 11,500 Repligen shares in Q3 2017, an estimated $477K.
Turner Investments first reported a position in Repligen in Q4 2014 and held it in 9 quarters.
Turner Investments's Repligen position peaked at $2.99M in Q1 2015.
190 funds tracked by Wall St. Rank held Repligen as of Q3 2017.

Based on Turner Investments's 13F filing for Q3 2017, filed 8 Nov 2017.